HOME >> BIOLOGY >> NEWS
Children's Hospital Boston receives more than $10 million to help make smallpox vaccine safer

Children's Hospital Boston (CHB) has secured contracts totaling nearly $10.5 million through the National Institutes of Health to study a potentially life-threatening complication of smallpox immunization known as eczema vaccinatum (EV). The goal is to reduce the risk of EV and develop a safer smallpox vaccine.

EV is a severe skin infection caused by vaccinia, the live virus used in the smallpox vaccine. The risk of EV has been a major barrier to reintroducing widespread smallpox immunization. Routine vaccination ended in the U.S. in 1972, so many Americans lack immunity to smallpox, which is now seen as a potential weapon of bioterrorism.

Most susceptible to EV are the millions of Americans, including many young children, who have a history of atopic dermatitis, the allergy-related skin condition better known as eczema. People with weakened immune systems also are at risk. If not treated in time, EV has a mortality rate of up to 6 percent, and as high as 30 percent among children under age 2.

CHB's Division of Immunology will play a leading role in a nationwide research network, launched by the National Institute of Allergy and Infectious Diseases (NIAID), that will investigate why atopic dermatitis predisposes smallpox vaccine recipients to EV.

"Since 5 percent of kids and about 1 percent of adults have atopic dermatitis, the risk is great should a decision be made to mass vaccinate," says Dr. Raif Geha, chief of Immunology at CHB. "EV can develop even in people with mild atopic dermatitis, as well as healthy people who had atopic dermatitis in the past. Also, since the virus in the smallpox vaccine is live, it can spread from contact with people who have been vaccinated."

Geha will head up the Animal Studies Consortium under the contract, coordinating animal studies at CHB and five subcontracting institutions under a five-year, $10 million grant. Geha's own lab will establish a mouse model for atopic dermatitis, explo
'"/>

Contact: Mary-Ellen Shay
mary.shay@childrens.harvard.edu
617-355-6420
Children's Hospital Boston
23-Jul-2004


Page: 1 2

Related biology news :

1. Childrens eating patterns show striking changes in two decades
2. Childrens Memorial, TGen announce partnership
3. Federal grant supports advances in infant heart disease at Childrens Hospital of Philadelphia
4. Packard Childrens Hospital gift creates new biotech research center for childrens health
5. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician
6. Childrens Hospital Boston researchers regenerate zebrafish heart muscle
7. Childrens Hospital Boston researchers use therapeutic cloning to create functional tissue in cows
8. Childrens book explores why animals stay home to help
9. Hopkins Childrens Center researchers find cause for common kind of dwarfism
10. Transplanted human stem cells develop into broad range of tissues, persist over a year in research at The Childrens Hospital of Philadelphia
11. Immunologist at the Childrens Hospital of Philadelphia receives national award in clinical laboratory immunology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
Breaking Biology News(10 mins):
(Date:9/19/2017)... Pleasanton, Calif. and Washington, D.C. (PRWEB) , ... ... ... to delivering rapid care during an biological outbreak is about to be eliminated, ... When asked what makes ExcitePCR’s FireflyDX™ technologies different than other pathogen ...
(Date:9/19/2017)... ... September 19, 2017 , ... Band-LOK, LLC, an orthopedic ... that two new patents have been allowed by the USPTO on the proprietary ... “We continue to explore additional clinically-relevant designs for both the implants and the ...
(Date:9/17/2017)... , ... September 17, 2017 , ... ... the South Korean Ministry of Food and Drug Safety (KMFDS) for an Investigational ... against the Middle East Respiratory Syndrome coronavirus (MERS-CoV). The study in Korea represents ...
(Date:9/14/2017)... ... , ... Boston Strategic Partners, Inc. (BSP), a life-sciences and ... Research (HEOR) and ‘big data’ to provide in-depth analysis of pneumonia patients characteristics, ... trillion with nearly 1/3 spent on hospitalizations. BSP has access to real-world data ...
Breaking Biology Technology:
Cached News: